Bayer appeals $20.5 million glyphosate-cancer verdict to California Supreme Court

Bayer AG has asked California’s Supreme Court to review a decision awarding $20.5 million to a groundskeeper who claimed the company’s Roundup weedkiller caused his cancer, arguing the ruling was at odds with federal law and settled legal principles.

Bayer, which acquired Roundup with its purchase of Monsanto for $63 billion in 2018, said the July decision by the California Court of Appeal affirming a 2018 jury verdict in favor of Dewayne Johnson would be relied upon by other courts handling cases over the widely used herbicide.

A San Francisco jury initially awarded Johnson $289.2 million after finding the chemical glyphosate in Roundup caused his non-Hodgkin’s lymphoma.

Related on the SLP

Supreme Court agrees to review Bayer’s request to block lawsuits claiming federally-approved herbicide glyphosate causes cancer Bayer won’t appeal first glyphosate-cancer verdict to the U.S. Supreme Court

As Europe inches forward in its embrace of gene-edited crops, hopes abound that opposition to GMOs might fade

Drugs and supplements can extend life and five other longevity myths

World Health Organization calls Kennedy- and CDC-backed Guinea-Bissau hepatitis B vaccine study designed to ‘prove’ the danger of vaccines “unethical”

The trial judge reduced that amount to $78.5 million. The Court of Appeal later reduced the damages to $20.5 million.

Read the original post